TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

BACKGROUND: Asthma is characterized by variable airflow obstruction and airway hyperresponsiveness in association with airway inflammation under the influence of T(H)2 cytokines. Eosinophilic bronchitis has similar immunopathology to asthma but without disordered airway physiology. Whether eosinoph...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Brightling, C, Symon, F, Birring, S, Bradding, P, Pavord, I, Wardlaw, A
Formato:	Journal article
Idioma:	English
Publicado em:	2002

Registos relacionados

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
Por: Brightling, C, et al.
Publicado em: (2003)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
Por: Berry, M, et al.
Publicado em: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
Por: Siddiqui, S, et al.
Publicado em: (2007)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
Por: Brightling, C, et al.
Publicado em: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
Por: Brightling, C, et al.
Publicado em: (2000)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
Por: Birring, S, et al.
Publicado em: (2003)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
Por: Brightling, C, et al.
Publicado em: (1999)

Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis.
Por: Birring, S, et al.
Publicado em: (2003)

Eosinophilic bronchitis is an important cause of chronic cough.
Por: Brightling, C, et al.
Publicado em: (1999)

Eosinophilic bronchitis - what is it and why is it important?
Por: Brightling, C, et al.
Publicado em: (2000)

Mepolizumab in refractory eosinophilic asthma.
Por: Pavord, I, et al.
Publicado em: (2010)

Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects.
Por: Woodman, L, et al.
Publicado em: (2006)

Eosinophilic bronchitis: an important cause of prolonged cough.
Por: Brightling, C, et al.
Publicado em: (2000)

Observational study of the natural history of eosinophilic bronchitis.
Por: Berry, M, et al.
Publicado em: (2005)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
Por: Berry, M, et al.
Publicado em: (2007)

Protracted bacterial bronchitis: bronchial aspirate versus bronchoalveolar lavage findings: a single-centre retrospective study
Por: Stijn Verhulst, et al.
Publicado em: (2019-12-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
Por: Brightling, C, et al.
Publicado em: (2000)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
Por: Mistry Vijay, et al.
Publicado em: (2009-07-01)

Mast-cell infiltration of airway smooth muscle in asthma.
Por: Brightling, C, et al.
Publicado em: (2002)

Non-eosinophilic corticosteroid unresponsive asthma.
Por: Pavord, I, et al.
Publicado em: (1999)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Por: Haldar, P, et al.
Publicado em: (2009)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Por: Green, R, et al.
Publicado em: (2002)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
Por: Brightling, C, et al.
Publicado em: (2003)

The significance of eosinophilic airway inflammation in asthma
Por: Pavord, I, et al.
Publicado em: (2002)

Eosinophils in asthma and other allergic diseases.
Por: Wardlaw, A, et al.
Publicado em: (2000)

A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet.
Por: Brightling, C, et al.
Publicado em: (2002)

Re-challenge with ovalbumin failed to induce bronchial asthma in mice with eosinophilic bronchitis.
Por: Liyan Chen, et al.
Publicado em: (2013-01-01)

Cytokine release syndrome after bronchoalveolar lavage
Por: Margaret Guerriero, et al.
Publicado em: (2023-10-01)

New insights into the role of the mast cell in asthma.
Por: Brightling, C, et al.
Publicado em: (2003)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Por: Shrimanker, R, et al.
Publicado em: (2017)

Eosinophils in asthma and airway hyperresponsiveness.
Por: Brightling, C, et al.
Publicado em: (2004)

A Patient with Bronchial Asthma in Whom Eosinophilic Bronchitis and Bronchiolitis Developed during Treatment
Por: Yasutsugu Fukushima, et al.
Publicado em: (2010-01-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Por: Shrimanker, R, et al.
Publicado em: (2017)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
Por: Saha, S, et al.
Publicado em: (2008)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Por: Haldar, P, et al.
Publicado em: (2014)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
Por: Bilocca, D, et al.
Publicado em: (2017)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
Por: Woltmann, G, et al.
Publicado em: (1999)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
Por: Wardlaw, A, et al.
Publicado em: (2004)

The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma
Por: Nair Parameswaran, et al.
Publicado em: (2011-03-01)

Association between lymphocyte count in bronchoalveolar lavage fluid and mortality
Por: Yifu Si, et al.
Publicado em: (2021-09-01)